Fluvoxamine for the treatment of COVID-19


Marzolini, Catia, Marra, Fiona, Boyle, Alison, Khoo, Saye ORCID: 0000-0002-2769-0967 and Back, David J (2022) Fluvoxamine for the treatment of COVID-19. LANCET GLOBAL HEALTH, 10 (3). E331-E331.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Humans, Fluvoxamine, SARS-CoV-2, COVID-19 Drug Treatment
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 07 Mar 2022 08:42
Last Modified: 08 Feb 2023 00:32
DOI: 10.1016/s2214-109x(21)00592-1
Open Access URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88466...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3150203
Dimensions
Altmetric
CORE (COnnecting REpositories)